has_Ingredient has_MoA has_PE drug associated with AE in adult drug associated with AE in pediatric used to treat disease HIV Protease Inhibitors [MoA] Increased Immunologically Active Molecule Activity [PE] atazanavir [Chemical/Ingredient] A [Preparations] ATAZANAVIR http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021567s026lbl.pdf 4024316 ATAZANAVIR 343047 Atazanavir Active <VANDF_Record>50.6^3890^</VANDF_Record><VA_File>50.6</VA_File><VA_IEN>3890</VA_IEN> Ingredient <VANDF_Record>50.416^4656^</VANDF_Record><VA_File>50.416</VA_File><VA_IEN>4656</VA_IEN> N0000022320 C1145759 C53848 human immunodeficiency virus infectious disease pain in extremity AE wheezing AE nasal congestion AE oropharyngeal pain AE rhinorrhea AE fever AE rash AE myalgia AE headache AE dizziness AE edema limbs AE cough AE abdominal pain AE jaundice AE depression AE nausea AE vomiting AE diarrhea AE insomnia AE